Hindustan Bio Sciences share price
BSE: 532041IT - SoftwareSmall Cap
Hindustan Bio Sciences Ltd. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹7.00up ₹0.20 (2.94%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹6.80.
29 Oct: open ₹6.85, high ₹7.04, low ₹6.46
52-week range of traded prices to 29 Oct 2026
₹5.00Low, 29 Dec 2025₹9.92High, 23 Apr 2026
- Under BSE's graded surveillance, stage 0, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 31 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7.18 Cr4,780th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.69
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.84
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,337
Results
Standalone; ₹ crore.Hindustan Bio Sciences quarterly results
Quarter to Jun 2026
- Revenue
- ₹0.00 Cr
- Net profit
- −₹0.11 Cr
Revenue by quarter
Peak revenue ₹0.38 Cr, quarter to Dec 2025; lowest ₹0.00 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 3 of the 6 quarters with results on record
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | – | 0.38 | 0.32 | 0.00 | 0.38 | – | 0.00 |
| Net profit | −0.05 | – | 0.11 | 0.01 | −0.06 | 0.08 | – | −0.11 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary | – | – | 28.8% | 4.3% | – | 21.4% | – | – |
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarters to Dec 2024 and Mar 2026.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.74 Crdown 9.37%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.08 CrYear to Mar 2025: ₹0.10 Cr
- Net margin
- −10.7%
Revenue by year
Peak revenue ₹3.56 Cr, year to Mar 2019; lowest ₹0.44 Cr, year to Mar 2022
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹0.08 CrA loss in 6 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.01 | 1.03 | 3.56 | 1.94 | 1.03 | 0.44 | 0.92 | 1.03 | 0.81 | 0.74 |
| Net profit | −0.49 | −2.28 | 0.11 | 0.08 | −0.94 | −0.52 | −0.04 | 0.06 | 0.10 | −0.08 |
| Net margin | −48.6% | −220.7% | 3.1% | 4.2% | −91.1% | −118.6% | −4.4% | 5.6% | 12.4% | −10.7% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, TRADING OF PHARMACUITICALS, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: less than a year of results in a row on record. Dividend yield is not shown: no dividend in the years on record.Hindustan Bio Sciences PE ratio and valuation
Price to book
At or below today's level on 43% of 1,125 trading days over the last 5 years.
LowestHighest
Its median9.25Industry median1.55
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +11.3% | – | – | 0.0% |
| 3 years | +13.5% | – | – | 0.0% |
| 5 years | +21.0% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Hindustan Bio Sciences insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Others2 purchases, 0 sales₹0.00 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.00 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Hindustan Bio Sciences competitors and peers
Software Products, 53 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Hindustan Bio Sciences in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.IT companies
Hindustan Bio Sciences is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Hit Kit Global SolutionsHITKITGLO | 12 | 140.23 | 0.94 | +30.8% | – | 0.7% | 0.1% | 0.00% |
 Groarc Industries IndiaGROARC | 12 | 5.53 | 0.30 | +1,041.4% | – | 5.4% | 2.8% | 0.00% |
 Clio InfotechCLIOINFO | 10 | 13.75 | 0.61 | +1,608.9% | +2,082.2% | 5.5% | 1.9% | 0.00% |
 Svam SoftwareSVAMSOF | 9 | – | 0.48 | +167.1% | – | −0.6% | −2.6% | 0.00% |
 Nihar Info GlobalNIHARINF | 5 | – | 0.80 | +123.7% | – | – | 18.0% | 0.00% |
 Seshachal TechnologiesSESHACHAL | 5 | – | 3.00 | +215.2% | −121.9% | −1.5% | −1.6% | 0.00% |
 Omni Axs SoftwareOMNIAX | 5 | – | 0.41 | – | – | – | – | 0.00% |
 Women NetworksWOMENNET | 4 | – | 0.63 | – | −846.8% | −7.6% | −1.4% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Hindustan Bio Sciences announcements
Oct 2026
26 Oct · Board meeting
Meeting on 31 Oct 2026: quarterly results
Sep 2026
30 Sep · Meeting
Hindustan Bio Sciences share price by year
Each calendar year to 2025.Hindustan Bio Sciences share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 5.27 | −48.4% | 10.32 | 5.03 |
| 2024 | 10.21 | +14.5% | 13.46 | 6.97 |
| 2023 | 8.92 | +135.4% | 14.46 | 3.68 |
| 2022 | 3.79 | −29.9% | 5.96 | 3.14 |
| 2021 | 5.41 | +18.4% | 5.41 | 2.67 |
| 2020 | 4.57 | +118.7% | 4.57 | 1.00 |
| 2019 | 2.09 | +102.9% | 3.18 | 0.77 |
| 2018 | 1.03 | +178.4% | 1.03 | 0.38 |
| 2017 | 0.37 | −83.4% | 2.50 | 0.37 |
| 2016 | 2.23 | −43.8% | 4.99 | 1.38 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2019 is from its first session, 11 Feb 2019. The 2018 close is its last trade, on 8 Oct 2018.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | 6.55 | 6.80 | 6.36 | 6.80 | 6.62 | 768 |
| 27 Oct 2026 | 6.85 | 6.85 | 6.24 | 6.68 | 6.31 | 2,695 |
| 26 Oct 2026 | 6.56 | 6.60 | 6.56 | 6.56 | 6.56 | 8,573 |
| 23 Oct 2026 | 6.98 | 6.98 | 6.64 | 6.90 | 6.72 | 5,976 |
| 22 Oct 2026 | 6.83 | 7.04 | 6.77 | 6.98 | 6.79 | 488 |
| 21 Oct 2026 | 6.61 | 7.24 | 6.61 | 6.77 | 7.04 | 8,124 |
| 19 Oct 2026 | 6.90 | 6.96 | 6.75 | 6.90 | 6.84 | 3,754 |
| 16 Oct 2026 | 6.89 | 7.20 | 6.70 | 7.10 | 6.79 | 4,192 |
| 15 Oct 2026 | 6.80 | 7.20 | 6.63 | 6.98 | 7.05 | 3,208 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 11 May 2023 | Price move | – | This is the share's first trade after a corporate action (Reduction of Capital, ex-date 3 Mar 2023), and the action's terms do not account for the move. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 532041
- ISIN
- INE597C01021
- Industry
- IT - Software
- Website
- www.hindustanbio.com
- CIN
- L26942TG1991PLC013564
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1991
- Registered office
- Sagar Society, Plot No 31, Road No 2, Banjara Hills, Hyderabad 500034, Telangana
- Share registrar
- Venture Capital & Corporate Investments Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments